journal
MENU ▼
Read by QxMD icon Read
search

CA: a Cancer Journal for Clinicians

journal
https://www.readbyqxmd.com/read/29927482/patient-selection-and-timing-of-allogeneic-hematopoietic-stem-cell-transplantation-for-relapsed-follicular-lymphoma
#1
Mike Fillon
No abstract text is available yet for this article.
June 21, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29927477/combined-physiologic-and-excisional-therapies-improve-cancer-related-lymphedema-outcomes
#2
Mike Fillon
No abstract text is available yet for this article.
June 21, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29889305/the-american-cancer-society-public-health-statement-on-eliminating-combustible-tobacco-use-in-the-united-states
#3
Clifford E Douglas, Rosie Henson, Jeffrey Drope, Richard C Wender
No abstract text is available yet for this article.
June 11, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29846954/from-guideline-to-practice-new-shared-decision-making-tools-for-colorectal-cancer-screening-from-the-american-cancer-society
#4
Robert J Volk, Viola B Leal, Lianne E Jacobs, Andrew M D Wolf, Durado D Brooks, Richard C Wender, Robert A Smith
No abstract text is available yet for this article.
May 30, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29846949/screening-for-colon-and-rectal-cancer-in-average-risk-adults
#5
(no author information available yet)
No abstract text is available yet for this article.
May 30, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29846947/colorectal-cancer-screening-for-average-risk-adults-2018-guideline-update-from-the-american-cancer-society
#6
Andrew M D Wolf, Elizabeth T H Fontham, Timothy R Church, Christopher R Flowers, Carmen E Guerra, Samuel J LaMonte, Ruth Etzioni, Matthew T McKenna, Kevin C Oeffinger, Ya-Chen Tina Shih, Louise C Walter, Kimberly S Andrews, Otis W Brawley, Durado Brooks, Stacey A Fedewa, Deana Manassaram-Baptiste, Rebecca L Siegel, Richard C Wender, Robert A Smith
In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guideline update, the American Cancer Society (ACS) used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence. Screening with any one of multiple options is associated with a significant reduction in CRC incidence through the detection and removal of adenomatous polyps and other precancerous lesions and with a reduction in mortality through incidence reduction and early detection of CRC...
May 30, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29846940/cancer-screening-in-the-united-states-2018-a-review-of-current-american-cancer-society-guidelines-and-current-issues-in-cancer-screening
#7
Robert A Smith, Kimberly S Andrews, Durado Brooks, Stacey A Fedewa, Deana Manassaram-Baptiste, Debbie Saslow, Otis W Brawley, Richard C Wender
Each year, the American Cancer Society publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates from the National Health Interview Survey, and select issues related to cancer screening. In this 2018 update, we also summarize the new American Cancer Society colorectal cancer screening guideline and include a clarification in the language of the 2013 lung cancer screening guideline. CA Cancer J Clin 2018. © 2018 American Cancer Society.
May 30, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29809280/ovarian-cancer-statistics-2018
#8
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel
In 2018, there will be approximately 22,240 new cases of ovarian cancer diagnosed and 14,070 ovarian cancer deaths in the United States. Herein, the American Cancer Society provides an overview of ovarian cancer occurrence based on incidence data from nationwide population-based cancer registries and mortality data from the National Center for Health Statistics. The status of early detection strategies is also reviewed. In the United States, the overall ovarian cancer incidence rate declined from 1985 (16.6 per 100,000) to 2014 (11...
May 29, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29851429/erratum-weight-management-and-physical-activity-throughout-the-cancer-care-continuum
#9
(no author information available yet)
No abstract text is available yet for this article.
May 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29603147/timely-follow-up-of-positive-cancer-screening-results-a-systematic-review-and-recommendations-from-the-prospr-consortium
#10
REVIEW
Chyke A Doubeni, Nicole B Gabler, Cosette M Wheeler, Anne Marie McCarthy, Philip E Castle, Ethan A Halm, Mitchell D Schnall, Celette S Skinner, Anna N A Tosteson, Donald L Weaver, Anil Vachani, Shivan J Mehta, Katharine A Rendle, Stacey A Fedewa, Douglas A Corley, Katrina Armstrong
Timely follow-up for positive cancer screening results remains suboptimal, and the evidence base to inform decisions on optimizing the timeliness of diagnostic testing is unclear. This systematic review evaluated published studies regarding time to follow-up after a positive screening for breast, cervical, colorectal, and lung cancers. The quality of available evidence was very low or low across cancers, with potential attenuated or reversed associations from confounding by indication in most studies. Overall, evidence suggested that the risk for poorer cancer outcomes rises with longer wait times that vary within and across cancer types, which supports performing diagnostic testing as soon as feasible after the positive result, but evidence for specific time targets is limited...
May 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29603144/pain-management-for-patients-with-cancer
#11
(no author information available yet)
No abstract text is available yet for this article.
May 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29603142/optimal-pain-management-for-patients-with-cancer-in-the-modern-era
#12
REVIEW
Bethann M Scarborough, Cardinale B Smith
Pain is a common symptom among patients with cancer. Adequate pain assessment and management are critical to improve the quality of life and health outcomes in this population. In this review, the authors provide a framework for safely and effectively managing cancer-related pain by summarizing the evidence for the importance of controlling pain, the barriers to adequate pain management, strategies to assess and manage cancer-related pain, how to manage pain in patients at risk of substance use disorder, and considerations when managing pain in a survivorship population...
May 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29574786/immune-checkpoint-inhibitors-are-superior-to-docetaxel-as-second-line-therapy-for-patients-with-non-small-cell-lung-carcinoma
#13
Mike Fillon
No abstract text is available yet for this article.
May 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29574775/internet-interventions-help-patients-newly-diagnosed-with-cancer-improve-their-quality-of-life
#14
Ted Gansler
No abstract text is available yet for this article.
March 25, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29573344/changes-in-inflammation-and-insulin-pathways-mediate-the-association-between-resistance-training-and-breast-cancer-survival
#15
Mike Fillon
No abstract text is available yet for this article.
March 24, 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29384589/who-s-still-smoking-disparities-in-adult-cigarette-smoking-prevalence-in-the-united-states
#16
REVIEW
Jeffrey Drope, Alex C Liber, Zachary Cahn, Michal Stoklosa, Rosemary Kennedy, Clifford E Douglas, Rosemarie Henson, Jacqui Drope
The continuing high prevalence of cigarette smoking among specific subpopulations, many of them vulnerable, is one of the most pressing challenges facing the tobacco control community. These populations include individuals in lower education and/or socioeconomic groups; from certain racial/ethnic groups; in the lesbian, gay, bisexual, and transgender community; with mental illness; and in the military, particularly among those in the lowest pay grades. Although traditional tobacco control measures are having positive health effects for most groups, the effects are not sufficient for others...
March 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29377070/factors-influencing-risk-based-care-of-the-childhood-cancer-survivor-in-the-21st-century
#17
REVIEW
Stephanie B Dixon, Kari L Bjornard, Nicole M Alberts, Gregory T Armstrong, Tara M Brinkman, Wassim Chemaitilly, Matthew J Ehrhardt, Israel Fernandez-Pineda, Lisa M Force, Todd M Gibson, Daniel M Green, Carrie R Howell, Sue C Kaste, Anne C Kirchhoff, James L Klosky, Kevin R Krull, John T Lucas, Daniel A Mulrooney, Kirsten K Ness, Carmen L Wilson, Yutaka Yasui, Leslie L Robison, Melissa M Hudson
The population of adult survivors of childhood cancer continues to grow as survival rates improve. Although it is well established that these survivors experience various complications and comorbidities related to their malignancy and treatment, this risk is modified by many factors that are not directly linked to their cancer history. Research evaluating the influence of patient-specific demographic and genetic factors, premorbid and comorbid conditions, health behaviors, and aging has identified additional risk factors that influence cancer treatment-related toxicity and possible targets for intervention in this population...
March 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29338071/the-financial-burden-and-distress-of-patients-with-cancer-understanding-and-stepping-up-action-on-the-financial-toxicity-of-cancer-treatment
#18
REVIEW
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder
"Financial toxicity" has now become a familiar term used in the discussion of cancer drugs, and it is gaining traction in the literature given the high price of newer classes of therapies. However, as a phenomenon in the contemporary treatment and care of people with cancer, financial toxicity is not fully understood, with the discussion on mitigation mainly geared toward interventions at the health system level. Although important, health policy prescriptions take time before their intended results manifest, if they are implemented at all...
March 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29319885/patient-selection-in-major-upper-abdominal-surgery-for-cancer-in-octogenarians
#19
Lara C Pullen
No abstract text is available yet for this article.
March 2018: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/29319847/decision-making-in-breast-cancer-risk-reduction
#20
Lara C Pullen
No abstract text is available yet for this article.
March 2018: CA: a Cancer Journal for Clinicians
journal
journal
20065
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"